FemHealth Ventures closes oversubscribed $65 million second fund to…

Team S · 2025-12-24T15:07:45.000Z

FemHealth Ventures, a Short Hills, New Jersey-based venture capital firm focused on breakthrough innovation in women’s health, has successfully closed its second fund at $65 million, more than doubling the size of its inaugural vehicle and bringing total assets under management to approximately $100 million across two funds. The oversubscribed raise reflects strong investor confidence in the firm’s specialised strategy and the expanding market opportunity within drugs, devices, diagnostics and digital/AI-enabled health technologies that address unmet needs for women. The fund received significant support from existing limited partners and new investors aligned with FemHealth Ventures’ mission to both generate strong financial returns and materially improve outcomes in women’s healthcare. Managing Partner Maneesha Ghiya highlighted that the successful close underscores growing recognition of women’s health as an investable category with meaningful societal impact, while Venture Partner Sara Crown Star emphasised the firm’s continued commitment to backing visionary founders building next-generation health innovations. FemHealth Ventures has become known in the sector for its three-category framework defining women’s health as conditions that appear only in women, mostly in women, or differently in women—a model widely referenced across the industry to guide research, strategy and investment. With Fund II now closed, the firm plans to accelerate investments across both clinical and digital segments of women’s health, partnering with companies positioned to transform care delivery and outcomes. #venturecapital #fundraising #FemHealthVentures #women’shealth #healthtech #VCfund #impactinvesting

Member Login Get Access

FemHealth Ventures closes oversubscribed $65 million second fund to… | Newnex